Home/Filings/4/0001209191-10-015517
4//SEC Filing

Mengler Christopher 4

Accession 0001209191-10-015517

CIK 0001003642other

Filed

Mar 8, 7:00 PM ET

Accepted

Mar 9, 1:54 PM ET

Size

5.8 KB

Accession

0001209191-10-015517

Insider Transaction Report

Form 4
Period: 2010-03-05
Mengler Christopher
President, Global Pharm. Div.
Transactions
  • Tax Payment

    Common Stock

    2010-03-05$16.48/sh2,294$37,80544,706 total
Footnotes (1)
  • [F1]These shares of common stock were surrendered upon vesting of a restricted stock award to satisfy the Reporting Person's payroll tax withholding obligations. Such surrender is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

Issuer

IMPAX LABORATORIES INC

CIK 0001003642

Entity typeother

Related Parties

1
  • filerCIK 0001336015

Filing Metadata

Form type
4
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 1:54 PM ET
Size
5.8 KB